Oscar Health stock (NYSE: OSCR) has recently increased to over $16 after reports of a possible two-year extension of Obamacare subsidies, which may positively influence demand for health insurance via ...

Tesla remains a Sell due to an unsustainable, overinflated valuation with a P/E of 322.44 and weak recent growth metrics. Q3 earnings showed record revenue and energy storage growth, but automotive ...

I upgraded MU to a Strong Buy after its 180% YTD rally, as its forward non-GAAP P/E fell to 14x, down from 16x in my last rating. The cheaper valuation is driven by significant upward revisions to ...